Want to see AU:CCO full AI Analyst Report?
CCO Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.01
AU$0.00(0.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.02
Previous CloseN/A
Volume184.12K
Average Volume (3M)17.77M
Market Cap
AU$10.56M
Enterprise ValueAU$8.67M
Total Cash (Recent Filing)AU$1.06M
Total Debt (Recent Filing)AU$4.30M
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding3,521,129,200
10 Day Avg. Volume17,774,369
30 Day Avg. Volume17,774,369
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.60
Price to Sales (P/S)0.62
P/FCF Ratio-1.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$16.03M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe company's revenue growth indicates increasing demand for its products, which can lead to improved market position and potential future profitability.
Market TrendsThe rising popularity of herbal supplements supports long-term growth prospects for Fiji Kava, aligning with consumer preferences for natural health products.
Brand ReputationStrong brand reputation and strategic partnerships enhance the company's market visibility and credibility, supporting sustainable revenue streams.
Bears Say
High LeverageHigh leverage poses a risk to financial stability, limiting the company's ability to invest in growth opportunities and manage economic downturns.
Profitability ChallengesOngoing profitability issues suggest operational inefficiencies and cost management challenges, impacting long-term financial health and investor confidence.
Cash Flow IssuesNegative cash flows indicate liquidity challenges, potentially hindering the company's ability to fund operations and invest in future growth initiatives.
Fiji Kava Limited News
CCO FAQ
What was Fiji Kava Limited’s price range in the past 12 months?
Fiji Kava Limited lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Fiji Kava Limited’s market cap?
Fiji Kava Limited’s market cap is AU$10.56M.
When is Fiji Kava Limited’s upcoming earnings report date?
Fiji Kava Limited’s upcoming earnings report date is Aug 28, 2026 which is in 38 days.
How were Fiji Kava Limited’s earnings last quarter?
Fiji Kava Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Fiji Kava Limited overvalued?
According to Wall Street analysts Fiji Kava Limited’s price is currently Overvalued.
Does Fiji Kava Limited pay dividends?
Fiji Kava Limited does not currently pay dividends.
What is Fiji Kava Limited’s EPS estimate?
Fiji Kava Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fiji Kava Limited have?
Fiji Kava Limited has 3,521,129,200 shares outstanding.
What happened to Fiji Kava Limited’s price movement after its last earnings report?
Fiji Kava Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Fiji Kava Limited?
Currently, no hedge funds are holding shares in AU:CCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fiji Kava Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.05%
Trailing 12-Months
Company Description
Fiji Kava Limited
The Calmer Co International Limited is a health and wellness enterprise focused on medicinal kava, conducting its operations in Australia, New Zealand, Fiji, and the United States. This company manufactures and distributes noble kava extract products, offered as both capsules and powder blends, under its well-known Fiji Kava and Taki Mai brands. Consumers can also acquire these items directly through fijikava.com. Founded in 2014 and based in West End, Australia, the entity rebranded to its current name in April 2023, having previously operated as Fiji Kava Limited.
EVE Health Group Limited
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Hydration Pharmaceuticals Co. Ltd.
―